By Codi Darnell February 22, 2022 Jane Austen said, “There is nothing like staying at home for real comfort” and I would have to agree with her. Your home is a place of refuge, set-up by you, for you. You know its quirks, like how to jiggle the handle just right to get the door unlocked […]
NervGen (TSX-V: NGEN, OTCQX: NGENF) is a clinical stage biotech company dedicated to developing innovative treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. NervGen’s lead drug candidate, NVG-291, is being evaluated in a Phase 1b/2a clinical trial. The company’s lead target indication is spinal cord injury.
Contact
112-970 Burrard Street
Unit 1290
Vancouver, BC V6Z 2R4
Phone: (778) 731-1711
Email: info@nervgen.com